Recently Taiwan stocks have been seeking new support amid volatility, with market attention once again focusing on domestic institutions' latest Q4 portfolios. This tracking report names 17 stocks in total, covering popular groups from semiconductors, cooling, networking, PCB materials to biotech, and simultaneously discloses each company's estimated EPS and target price, becoming an important reference amid changing market conditions. Overall, institutional positioning continues the main theme of strength begetting strength and trend reigning supreme.
Semiconductors Remain at the Core
As the pillar of Taiwan stocks, wafer foundry leader台積電 (2330) is estimated to reach EPS of 111.6 yuan this year, with an annual growth rate of 68.4%, and a target price of 3300 yuan. IC packaging and testing major日月光投控 (3711) has estimated EPS of 27.3 yuan and a target price of 820 yuan. In IC design and design services, 聯發科 (2454) driven by strong revenue momentum has estimated EPS of 157.4 yuan and a target price of 6000 yuan. 創意 (3443) benefiting from high-speed computing demand has estimated EPS of 130.2 yuan and a target price of 10000 yuan. In the memory group, 南亞科 (2408) and 華邦電 (2344) despite short-term noise over expansion concerns about Chinese manufacturers have estimated EPS of 76.1 yuan and 27.0 yuan respectively, with target prices of 800 yuan and 300 yuan respectively, and their outlook remains in market focus.
AI Hardware Chain Focuses on Cooling and PCB
The hardware revolution driven by AI servers continues, with cooling and PCB materials becoming the focus of the AI infrastructure chain. Cooling indicator 奇鋐 (3017) despite a slight downward revision in vapor plate shipments due to unsmooth AWS water-cooling cabinet shipments still has estimated EPS of 196.4 yuan and a target price of 4910 yuan. Assembly major 緯創 (3231) has estimated EPS of 18.6 yuan and a target price of 315 yuan. In power supplies, 光寶科 (2301) has estimated EPS of 9.6 yuan and a target price of 350 yuan. 台達電 (2308) affected in market confidence by the VICOR patent dispute has estimated EPS of 40.0 yuan and a target price of 2100 yuan. In PCB materials needed for high-frequency high-speed applications, 台光電 (2383) has estimated EPS of 113.1 yuan and a target price of 6000 yuan. 聯茂 (6213) has estimated EPS of 19.1 yuan and a target price of 750 yuan. In networking and other sub-groups, 聯亞 (3081) has estimated EPS of 21.8 yuan and a target price of 3825 yuan. 統新 (6426) has estimated EPS of 7.0 yuan and a target price of 490 yuan. 矽格 (6257) has estimated EPS of 9.9 yuan and a target price of 331 yuan, each showing its industrial niche.
Traditional Industries and Biotech Advance on Dual Tracks
In addition to technology stocks, traditional industries and biotech healthcare are also highlights named by institutions. In auto parts, 百達-KY (2236) is estimated to turn from loss to profit with EPS of 0.9 yuan this year and a target price of 160 yuan. 智伸科 (4551) has estimated EPS of 10.8 yuan and a target price of 250 yuan. In biotech new drugs, 藥華藥 (6446) with strong revenue performance has estimated EPS of 25.3 yuan and a target price of 1410 yuan. 保瑞 (6472) has estimated EPS of 15.0 yuan and a target price of 503 yuan. Overall, institutional positioning shows defense and growth advancing on dual tracks, investors can refer to the data and target prices, carefully assess risks, and find a positioning rhythm suitable for themselves. Investment always involves risks, decisions should be carefully evaluated and at one's own risk.